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Abstract 
Background: Guillain-Barré Syndrome is a progressive autoimmune polyradiculoneuropathy characterized by symmetrical flaccid paralysis accompanied by 
areflexia, hyporeflexia or hyperreflexia on rare occasions. Worldwide, it remains the first cause of flaccid paralysis. It is usually associated with infectious 
disease history; however, there are various clinical variants, each with a different outcome. Prognosis is usually good, although 20% of patients could 
suffer a severe clinical variant of Guillain-Barré Syndrome and 5% will die despite treatment. Methods: This is a cross-sectional study, including the records 
of hospitalized patients with Guillain- Barré Syndrome at Mexicali’s General Hospital within a five-year period. Results: In a five-year span there were 64 
patients with Guillain-Barré Syndrome, most of the patients were men (70.3%), with age ranging 1 to 76 years. A total of 8 (12.5%) patients died, from 
which 7 (87.5%) required mechanical ventilation during hospitalization. Immunoglobulin therapy was provided to 56 (87.5%) patients, and 6 (10.7%) of 
them perished due to acute kidney injury. Conclusion: Guillain-Barré Syndrome is a common disease among male population, with no dominating onset 
age, however, leaning for the young and elder. Most of the patients that were hospitalized at the General Hospital of Mexicali had a history of previous 
infection (gastrointestinal, respiratory, or other infectious diseases). The need for mechanical ventilation represents a higher severity index, nonetheless, 
this does not mean that assisted ventilation is directly associated with mortality. As for treatment, immunoglobulin is the most common choice for therapy, 
though some of the patients died from acute kidney injury. 
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Introduction 
Landry-Guillain-Barré Strohl Syndrome is a progressive autoimmune 
polyradiculoneuropathy,1 characterized by symmetrical flaccid paralysis 
with areflexia, hyporeflexia or hyperreflexia on very rare occasions.2 
Worldwide, it remains the first cause of flaccid paralysis. It is usually 
associated with a previous infectious disease; however, this is not 
always the case. There are various clinical variants, each with a 
different prognosis and mortality. Prognosis is usually good, although 
20% of patients could suffer a severe clinical variant of Guillain-Barré 
Syndrome (GBS) and 5% will die despite treatment.3-4 
 
Nowadays, in the post-polio era, Guillain-Barré Syndrome is the most 
common cause of acute flaccid paralysis of healthy individuals. It has 
a worldwide incidence of 1-2 adults per 100,000 per year, mainly 
affecting male population. There is no dominant age group, however, 
the incidence increases 20% every 10 years from the first decade of 
life.5,6 While in México, Domínguez-Moreno reported an incidence of 
0.89-1.89/100,000 people per year,7 from our knowledge, there are not 
studies regarding Guillain-Barré Syndrome’s epidemiology in the city of 
Mexicali, México, being the main reason for this study to be conducted. 
 
There is not a specific etiology for the disease; however, it may occur 
in association with multiple viral or bacterial infections, many agents 
have been linked as a precipitating factor, for example, Campylobacter 
jejuni,8 Escherichia coli, Mycoplasma pneumoniae, and viruses like 
cytomegalovirus, Epstein-Barr, human immunodeficiency virus, herpes 
zoster, and hepatitis. A study carry out in a city of México documented 
eleven cases of GBS from January to March 2017, 23% were associated 
with Zika virus, 7% non-polio enteroviruses and 38% Campylobacter.9 A 
previous infection may trigger immune response that leads to acute 
polyneuropathy, approximately two-thirds of the patients refer a 
previous gastrointestinal or respiratory infection. In other studies, a 
small percentage of patients who have a history of vaccination, surgery, 
trauma or bone marrow transplant have also developed the disease.6 
 
Clinical symptoms are broad and therefore misleading during diagnosis. 
Typically, it appears as a rapidly progressive symmetrical muscle 
weakness with absent, decreased or augmented deep tendon reflexes.1 
Weakness may range from mild motor impairment to complete 
paralysis of facial, respiratory or bulbar muscles, and limbs. Some 
unusual features include papilledema, myokymia, decreased auditory 
acuity, meningeal signs, vocal cord paralysis, and impaired alertness.5,10 
 
In a prospective, observational, international study that included a 
thousand patients from Europe, America, Asia and Bangladesh with 
Guillain-Barré Syndrome, they identified numerous clinical variants 
(Table 1) and their frequency according to geographical region, 
concluding that in North America the most common subtype is 
sensorimotor (69)%.11 
 
Electrophysiological studies have a crucial role in confirming the 
diagnosis and classifying the main variants as demyelinating or axonal. 
It's hard to distinguish subtypes on clinical features alone. Findings can 
be normal early in the course but appear to be altered two weeks after 
the onset of symptoms.12 
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The aim of this study was to describe the clinical features of patients 
with GBS who were hospitalized at the General Hospital of Mexicali in 
a period (2014-2019), and their relationship with mortality. 
 
Table 1. Guillain-Barré Syndrome clinical variants.11 
 
Acute inflammatory demyelinating polyneuropathy 
Acute motor axonal neuropathy (AMAN) 
Acute motor and sensory axonal neuropathy (AMSAN) 
Miller Fisher syndrome 
Bickerstaff encephalitis 
Pharyngeal-cervical-brachial weakness 
Paraparesis 
Acute pandysautonomia 
Pure sensory GBS 
Facial diplegia and distal limb paresthesia 
Acute bulbar palsy with areflexia 
 
Methods 
This is a cross-sectional study, including the records of hospitalized 
patients with Guillain- Barré Syndrome at Mexicali’s General Hospital 
within a five-year period. Sensitive information, such as name, 
remained in anonymity. The patients involved were assessed by 
medical staff who evaluated the presence of the Asbury and Cornblath 
criteria for diagnosis.13  
 
The General Hospital of Mexicali is a public institution owned by the 
government with the objective to grant financial protection for patients 
who lack of social security, ensuring their access to health services. 
This is one of the many public hospitals that allows medical students 
to learn by enrolling on their academic programs. It is empirically 
known that the incidence of the disease has been on the rise over the 
past few years, suggesting that the study of the disease may be 
relevant to the community. 
 
The following variables were analyzed: age, gender, time of onset, 
prodromal infections (gastrointestinal, respiratory or other), 
mechanical ventilation use, acute kidney injury, cranial nerve affection 
and choice of treatment. We studied cerebral spine fluid cell count, 
glucose and protein level, to consider albumin-cytological dissociation 
(protein levels were higher than 40 mg/dL and a cell count lower than 
10 cells/mm3).3  
 
Nerve conduction studies were only performed in patients whose 
diagnosis was uncertain, however, the reliability for neurophysiological 
criteria for diagnosis early in the course of GBS has yet to be 
determined.14  
 
Results were considered significant if p-value < 0.05. Tables of 
categorical variables were analyzed for heterogeneity by the x2 test, 
using Yates’ continuity correction for two-by-two tables, or Fisher’s 
exact test if expected frequencies were less than 5. Student’s t-test was 
conducted to compare continuous variables between two groups. Data 
were analyzed by the Epi-Info statistical package version 7.2.2.16 and 
with Microsoft Office Excel (2018). 
 
This study has been approved by the Institutional Review Board of the 
General Hospital of Mexicali. 
 
Results 
This study included 64 patients diagnosed with Guillain-Barré Syndrome 
within 5 years (2014-2019), 45 (70.3%) male patients and 19 (29.7%) 
female patients. Age ranged from 1 through 76 years, with an average 
age of onset of 35 years old. The most affected age ranges were 1-12 
years and 41-59 years (21.88% both), however, the mortality rate 
increased with age (Figure 1). We estimated an incidence of 4 patients 
per 100,000 per year, meaning it has a high epidemiological impact. 
 
Figure 1. Mortality and patients’ age at diagnosis 
 
 
 
Some patients presented with neurological symptoms 4 days before 
seeking medical attention (54%) and others suffered from respiratory 
or gastrointestinal infection before the start of neurological symptoms 
(55%), 20% and 59.3% respectively, while 14.6% patients refused to 
have respiratory or digestive infection, but presented other infections 
such as urinary tract infection, HIV, and hepatitis C virus. 
 
The global mortality rate was 12.7%. From the 70.3% males included in 
this study, 9% passed away, compared to the 30.16% female patients, 
from which 21.05% of them died. (OR=0.37 95%CI 0.8-1.6). 
 
As for mechanical ventilation, 28% required it during the course of the 
disease, with an outcome of 87.5% deaths (p-value <0.01). 6.3% 
developed acute kidney injury during hospitalization, all of them 
received immunoglobulin therapy, yet the sample size of the 
unexposed was too small to establish a statistical significance. Of the 
55 patients who received immunoglobulin, 4 (7.3%) developed acute 
kidney injury and 6 (10.9%) of them perished. There were 8 (12.5%) 
patients who did not receive any type of treatment (immunoglobulin 
or plasmapheresis), and 2 (25%) of them died. One of the patients who 
received immunoglobulin had previously received immunoglobulin 
therapy 15 years ago due to an earlier episode of Guillain-Barré Syndrome 
and had to interrupt treatment because he developed anaphylactic shock 
and acute kidney injury during administration. This patient did not live, 
despite receiving hemodialysis and plasmapheresis (Table 2). 
 
Table 2. Study results 
 
Variable Freq. (%) Death (%) OR (95% CI) 
Total 64 (100) 8 (12.7)  
Men 45 (70.3) 4 (9) 1 
Women 19 (30.16) 4 (21.05) 0.37 (0.8-1.6) 
Previous infection 55 (86) 7 (12.7) 1.16 (0.12-10.8) 
Gastrointestinal 38 (59.3) 6 (15.7) 2.2 (0.4-12.1) 
Respiratory 13 (20) 2 (25) 1.3 (0.2-7.7) 
Other 9 (14) 1 (12.5) 0.8 (0.09-7.9) 
Mechanical ventilation  18 (28.5) 7 (87.5) 28 (3.11-251) 
Acute kidney injury  4 (6.3) 1 (25) 2.5 (0.22-27.2) 
Cranial nerve affection 20 (31.25) 1 (5) 0.2 (0.0.3-2.4) 
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Discussion 
This study reviewed 64 cases of patients with GBS from 2014 through 
2019, 70.3% were male and 30.16% were female with an obvious incline 
for males just like Carrillo-Pérez et al stated.15 The average age of onset 
was 35 years, unlike Medina-Benites et al who reported an average of 
43.85 years;3 no predominant age range was observed for the onset of 
the disease, however, there is an increased incidence in young and 
elderly patients. While analyzing the data, an association between age 
and mortality was observed, demonstrating that age is directly 
proportional to mortality (p < 0.0001). 
 
From the total of patients, 86% reported having had a previous infection 
from which 59.3% were gastrointestinal and 20% respiratory, unlike 
other studies where only 77% presented a previous infectious disease.16 
During characterization no patients were found with a history of 
trauma, surgery or vaccination, however, different studies reported 
there is an increased incidence after vaccination or surgery.17 
 
Mechanical ventilation is associated to a poor outcome, and it is not a 
predictor for prognosis, yet, it is an indicator of a severity of the 
disease. It is well elucidated that the need for mechanical ventilation 
for acute respiratory failure translates severity. In this study 7 (10.9%) 
patients perished while on mechanical ventilation. In other studies the 
need for mechanical ventilation was compared to the history of 
previous infections, 52% presented a respiratory infection from which 
28% required mechanical ventilation.16 Furthermore, another study 
mentioned that only 13% of the study population (total of 8,364 
patients) needed mechanical ventilation, although they had a larger 
number of patients. 17 
 
Regarding treatment, immunoglobulin was administered to 56 (87.5%) 
patients, 6 expired as they developed acute kidney injury, 
unfortunately, the sample size does was not enough to establish a 
relationship between acute kidney injury and the use of 
immunoglobulin, moreover, only one patient was treated with 
plasmapheresis ending in death since he had severe clinical disease 
and similarly developed acute kidney injury. In other studies treatment 
is divided into supportive measures, immunoglobulin and 
plasmapheresis (19%, 57%, 23% respectively) with a total of 21 without 
relating to mortality,3 whereas in another study with 25 patients where 
most received plasmapheresis (52%) no significant change was found 
in disease progression.14 The decision to administer immunoglobulin 
may be affected by the fact that ours is a public hospital, sometimes 
with limited resources, therefore, the availability of supplies may be 
affected. 
 
This is a retrospective study, with obvious weaknesses involved. For 
example, the lack of information on some patients’ records. Similarly, 
the score of Erasmus for outcome in Guillain-Barré Syndrome or the 
modified disability scale for GBS was not applied in this study.3 
 
The incidence rate for GBS in our city is 4 per 100, 000 individuals per 
year, being twice as much as a previous study conducted in our 
country. We noted a higher prevalence among male sex, just like the 
rest of the studies regarding GBS, this without being a risk factor for 
mortality. Also, there is no prevailing onset age. The need for 
mechanical ventilation represents a higher severity index, nonetheless, 
this does not mean that assisted ventilation is directly associated with 
mortality. As for therapy, the use of immunoglobulin as first-choice 
treatment was associated with acute kidney injury, without an 
increment in mortality, though results were not statistically significant 
due to the size of our sample.  
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